In the world of rare diseases, one condition is quietly making waves in both medical circles and investment portfolios. Acromegaly, a hormonal disorder caused by excess growth hormone, might not be a household name, but it’s sparking a surge of innovation and opportunity in the Acromegaly Treatment Market. Often developing slowly over years, acromegaly is typically caused by benign tumors...